Article
MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance
3 Jan 2014
Abstract excerpt
BACKGROUND: Development of resistance to androgen deprivation therapy (ADT) is a major obstacle for the management of advanced prostate cancer. Therapies with androgen receptor (AR) antagonists and androgen withdrawal initially regress tumors but development of compensatory mechanisms including AR bypass signaling leads to re-growth of tumors. MicroRNAs (miRNAs) are small regulatory RNAs that are involved in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
